CIBMTR Reporting Implementation Guide
0.1.8 - Trial Use 1
CIBMTR Reporting Implementation Guide
0.1.8 - Trial Use 1
This page is part of the CIBMTR Reporting Implementation Guide (v0.1.8: Release Draft) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions
| Official URL: http://fhir.nmdp.org/ig/cibmtr-reporting/ValueSet/med-bortezomib-vs | Version: 0.1.8 | |||
| Draft as of 2025-02-18 | Computable Name: RxNormBortezomibVS | |||
RxNorm codes for Bortezomib
References
This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)
Generated Narrative: ValueSet med-bortezomib-vs
http://www.nlm.nih.gov/research/umls/rxnorm| Code | Display |
| 358258 | bortezomib |
| 356733 | Velcade |
| 1804993 | bortezomib 3.5 MG |
| 1804996 | bortezomib 3.5 MG [Velcade] |
| 402244 | bortezomib 3.5 MG Injection [Velcade] |
| 1163075 | bortezomib Injectable Product |
| 1804994 | bortezomib Injection |
| 1804997 | bortezomib Injection [Velcade] |
| 1187756 | Velcade Injectable Product |
Generated Narrative: ValueSet
Expansion from tx.fhir.org based on codesystem RxNorm version09032024
This value set contains 9 concepts
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |